| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/02/1996 | CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 05/02/1996 | CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | CA2203363A1 Binding agents to cd23 |
| 05/02/1996 | CA2203165A1 Synthetic ige membrane anchor peptide immunogens for the treatment of allergy |
| 05/02/1996 | CA2203105A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 05/02/1996 | CA2202912A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding |
| 05/02/1996 | CA2200427A1 Receptor for a bacillus thuringiensis toxin |
| 05/01/1996 | EP0709460A1 Coccidiosis poultry vaccine |
| 05/01/1996 | EP0709455A1 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody |
| 05/01/1996 | EP0709397A1 p53as Protein and antibody therefor |
| 05/01/1996 | EP0709396A1 Gamma T cell receptor and methods for detection |
| 05/01/1996 | EP0709097A1 Anti-Fas antibody for rheumatic disease |
| 05/01/1996 | EP0708841A1 Method of identifying human and animal cells capable of unlimited proliferation or tumour formation |
| 05/01/1996 | EP0708833A1 Herpes simplex virus type-2 protease |
| 05/01/1996 | EP0708832A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
| 05/01/1996 | EP0708831A1 Density enhanced protein tyrosine phosphatases |
| 05/01/1996 | EP0708767A1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
| 05/01/1996 | EP0708661A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| 05/01/1996 | EP0708659A1 Hiv envelope polypeptides |
| 05/01/1996 | EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 05/01/1996 | EP0491031B1 Cdr grafted anti-cea antibodies and their production |
| 05/01/1996 | EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates |
| 05/01/1996 | CN1121725A Immunoparticles bearing monoclonal anti-CD4 antibodies and utilisation thereof |
| 05/01/1996 | CN1031714C Process for preparing urinary follicle stimulating hormone |
| 05/01/1996 | CA2161480A1 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody |
| 04/30/1996 | US5512660 Purified ICAM-2 and fragment thereof |
| 04/30/1996 | US5512657 Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases |
| 04/30/1996 | US5512548 CETP inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 04/30/1996 | US5512544 Pharmaceutical compositions comprising an anticytokine |
| 04/30/1996 | US5512457 Cytokine designated elk ligand |
| 04/30/1996 | US5512455 Atrial natriuretic peptide receptor protein |
| 04/30/1996 | US5512443 Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same |
| 04/30/1996 | US5512442 Using specific antibody binding |
| 04/30/1996 | US5512435 Receptor-binding antiproliferative peptides |
| 04/30/1996 | US5512288 Administering culture product from medium containing bile |
| 04/30/1996 | US5512283 Methods for the selective suppression of an immune response to dust mite der Pi |
| 04/30/1996 | US5512282 Purified immunoglobulins comprising monospecific polyclonal antibodies to shiga-like toxin obtained by innoculating bovine animal with active shiga-like toxin, recovering immunoglobulins after animal has immune response to toxin |
| 04/25/1996 | WO1996012193A1 Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen |
| 04/25/1996 | WO1996012192A1 Antibodies against an extracellular matrix complex and their use in the detection of cancer |
| 04/25/1996 | WO1996012191A1 STABILISING MEDIUM FOR αGST IN URINE FOR USE IN AN ENZYME IMMUNOASSAY |
| 04/25/1996 | WO1996012190A2 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 04/25/1996 | WO1996012189A3 METHODS OF SCREENING FOR ULCERATIVE COLITIS AND CROHN'S DISEASE BY DETECTING VH3-15 AUTOANTIBODY AND pANCA |
| 04/25/1996 | WO1996012189A2 METHODS OF SCREENING FOR ULCERATIVE COLITIS AND CROHN'S DISEASE BY DETECTING VH3-15 AUTOANTIBODY AND pANCA |
| 04/25/1996 | WO1996012185A1 Method for screening compositions |
| 04/25/1996 | WO1996012033A1 Polycystic kidney disease gene |
| 04/25/1996 | WO1996012024A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 04/25/1996 | WO1996012019A2 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family |
| 04/25/1996 | WO1996011955A1 Antigen-binding fusion proteins |
| 04/25/1996 | WO1996011948A1 Neurotrophic peptides of activity dependent neurotrophic factor |
| 04/25/1996 | WO1996011946A1 Human endothelin-bombesin receptor |
| 04/25/1996 | WO1996011706A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
| 04/25/1996 | WO1996011664A2 Nsk2 a muscle receptor tyrosine kinase |
| 04/25/1996 | WO1996004557A3 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 04/25/1996 | CA2202680A1 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 04/25/1996 | CA2202622A1 Use of protease inhibitors and protease vaccines to protect animals from flea infestation, and flea protease proteins, nucleic acid molecules and uses thereof |
| 04/25/1996 | CA2202533A1 Her4 human receptor tyrosine kinase |
| 04/25/1996 | CA2202283A1 Polycystic kidney disease gene |
| 04/25/1996 | CA2202072A1 Methods of screening for ulcerative colitis and crohn's disease by detecting vh3-15 autoantibody and panca |
| 04/24/1996 | EP0708178A1 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 04/24/1996 | EP0707652A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof |
| 04/24/1996 | EP0707651A1 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA) |
| 04/24/1996 | EP0707649A1 Cisplatin resistance gene and uses therefor |
| 04/24/1996 | EP0707648A1 Platelet glycoprotein v gene and uses |
| 04/24/1996 | EP0707647A1 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
| 04/24/1996 | EP0707489A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 04/24/1996 | EP0707485A1 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 04/24/1996 | EP0380542B1 Method for treating malignancy and autoimmune disorders in humans |
| 04/24/1996 | CN1121357A Hepatitis B escape mutant specific binding molecules |
| 04/24/1996 | CN1121312A Chlamydia vaccine and process |
| 04/23/1996 | US5510466 Scavenger receptor protein and antibody thereto |
| 04/23/1996 | US5510465 Generating non-specific complement activation in reduced amount in an in vitro assay while being capable of retaining antigen binding and specific complement activating activity |
| 04/23/1996 | US5510270 Generating pattern of light and dark areas by selectively irradiating surface areas; deprotecting; contacting with receptor to identify oligonucleotide showing complementarity to receptor |
| 04/23/1996 | US5510264 Antibodies which bind meningitis related homologous antigenic sequences |
| 04/23/1996 | US5510263 Growth of pancreatic islet-like cell clusters |
| 04/23/1996 | US5510259 Isolated, purified dna having nucleotide sequence coding for said molecule |
| 04/23/1996 | US5510241 Using monoclonal antibodies |
| 04/23/1996 | US5510240 Method of screening a peptide library |
| 04/23/1996 | US5510105 Lysing unwanted non-malignant cells(lymphocytes)involved in transplant rejection in a mammal |
| 04/18/1996 | WO1996011271A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
| 04/18/1996 | WO1996011263A1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria |
| 04/18/1996 | WO1996011260A1 Patched genes and their use |
| 04/18/1996 | WO1996011212A1 Novel receptor-type tyrosine kinase ligand |
| 04/18/1996 | WO1996011208A1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 04/18/1996 | WO1996011020A1 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 04/18/1996 | WO1996011013A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 04/18/1996 | WO1996011012A1 Hematopoietic cell l-selectin ligand (hll) and therapeutics thereof |
| 04/18/1996 | WO1996010911A1 Cytokine designated lerk-6 |
| 04/18/1996 | WO1996007739A3 Interleukin-1 type 3 receptors |
| 04/18/1996 | WO1996001317A3 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 04/18/1996 | DE4436558A1 Prepn. of vaccine against allergy inducing cpds. |
| 04/18/1996 | DE19507166C1 Antibodies specific for fusion polypeptide(s) contg. a histidine component |
| 04/18/1996 | CA2202472A1 Hematopoietic cell l-selectin ligand (hll) and therapeutics thereof |
| 04/18/1996 | CA2201616A1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria |
| 04/18/1996 | CA2201132A1 Cytokine designated lerk-6 |
| 04/17/1996 | EP0706799A2 Immunoconjugates II |
| 04/17/1996 | EP0706656A1 Immunoassay for soluble fibrin polymers |
| 04/17/1996 | EP0706655A1 Mca assay/kit for detecting metal cations |
| 04/17/1996 | EP0706571A1 Tuberculosis vaccine |
| 04/17/1996 | EP0706569A1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |